These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 14250646)
1. AZETEPA (NSC-64826) IN STAGE IV BREAST CANCER. FALKSON G; FALKSON HC Cancer Chemother Rep; 1964 Dec; 43():19-24. PubMed ID: 14250646 [No Abstract] [Full Text] [Related]
2. Clinical experience with a new alkylating agent, azetepa, in a variety of solid tumors. CHOY DS; STYLIANOU S Cancer Chemother Rep; 1962 Oct; 23():47-50. PubMed ID: 14021063 [No Abstract] [Full Text] [Related]
3. Clinical evaluation of a new alkylating agent, azetepa, in one hundred and twenty-five cases of malignant tumors. Choy DS; Arandia J; Rosenbaum I Int J Cancer; 1967 Mar; 2(2):189-93. PubMed ID: 6039768 [No Abstract] [Full Text] [Related]
4. "AZETEPA": A NEW ALKYLATING AGENT. MCLEAN JA Med J Aust; 1965 Apr; 1(17):620-3. PubMed ID: 14293517 [No Abstract] [Full Text] [Related]
5. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS. SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900 [No Abstract] [Full Text] [Related]
6. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS. BARDOS TJ; DATTA-GUPTA N; HEBBORN P; TRIGGLE DJ J Med Chem; 1965 Mar; 8():167-74. PubMed ID: 14335145 [No Abstract] [Full Text] [Related]
7. [Anticancer chemotherapy with evaluation of combined treatments]. Saito T Poumon Coeur; 1968; 24(1):129-31. PubMed ID: 5652199 [No Abstract] [Full Text] [Related]
14. THE ACTIVATION OF EXPERIMENTAL AND CLINICAL IMMUNOLOGIC DISEASES BY X-IRRADIATION AND ALKYLATING AGENTS. SCHWART RS Ann N Y Acad Sci; 1965 Mar; 123():64-77. PubMed ID: 14329221 [No Abstract] [Full Text] [Related]
15. ARISTOLOCHIC ACID (NSC-50413): PHASE I CLINICAL STUDY. JACKSON L; KOFMAN S; WEISS A; BRODOVSKY H Cancer Chemother Rep; 1964 Nov; 42():35-7. PubMed ID: 14226128 [No Abstract] [Full Text] [Related]
16. PRACTICAL AND USEFUL DRUG THERAPY AGAINST CANCER. SAMP RJ SD J Med Pharm; 1964 Sep; 17():17-21. PubMed ID: 14174187 [No Abstract] [Full Text] [Related]
17. 6-THIOGUANINE (NSC-752)-1 THERAPY IN PATIENTS WITH MULTIPLE MYELOMA. CARBONE PP; FREI E; OWENS AH; OLSON KB; MILLER SP Cancer Chemother Rep; 1964 Mar; 36():59-62. PubMed ID: 14152276 [No Abstract] [Full Text] [Related]
18. [CYTOSTATIC THERAPY WITH ALKYLATING AGENTS FOR MALIGNANT TUMORS]. SCHUMACHER K; LANGE J Dtsch Med J; 1964 Nov; 15():761-5. PubMed ID: 14329920 [No Abstract] [Full Text] [Related]
19. CLINICAL EVALUATION OF VINCRISTINE (NSC-67574). SHAW RK; BRUNER JA Cancer Chemother Rep; 1964 Nov; 42():45-8. PubMed ID: 14226130 [No Abstract] [Full Text] [Related]
20. [Chemotherapy of cancer]. Saito T Gan No Rinsho; 1968 Jan; 14(1):71-3. PubMed ID: 5692170 [No Abstract] [Full Text] [Related] [Next] [New Search]